Genicular Artery Embolization (GAE) for the Treatment of Chronic Post Knee Arthroplasty Pain

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 1, 2022

Primary Completion Date

July 1, 2023

Study Completion Date

September 1, 2023

Conditions
Knee Pain ChronicKnee Swelling PainArterial Occlusion
Interventions
DEVICE

Embozene Microspheres

"Embozene Microspheres are manufactured by Varian Medical Systems (Palo Alto, CA). These microspheres are non-resorbable hydrogel microspheres coated with polyzene-F. Embozene microspheres are approved for use in treating arteriovenous malformations, hypervascular tumors such as uterine fibroids and hepatomas, and prostatic arteries in patients with benign prostatic hyperplasia.~One of the causes of chronic pain in the setting of a knee arthroplasty may be increased blood flow to the specific area(s) of pain. The purpose of this procedure is to reduce blood flow (embolize) to specific parts of the knee which are contributing to your pain.~This procedure is performed by infusing the Embozene particles into specific knee arteries (genicular arteries) in the region of knee pain."

Trial Locations (1)

02115

Brigham & Women's Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Guerbet

INDUSTRY

lead

Brigham and Women's Hospital

OTHER

NCT05248308 - Genicular Artery Embolization (GAE) for the Treatment of Chronic Post Knee Arthroplasty Pain | Biotech Hunter | Biotech Hunter